Literature DB >> 7834213

Block of human voltage-sensitive Na+ currents in differentiated SH-SY5Y cells by lifarizine.

N A Brown1, J A Kemp, G R Seabrook.   

Abstract

1. The ability of lifarizine (RS-87476) to block human voltage-sensitive Na+ channel currents was studied by use of whole cell patch clamp recording from differentiated neuroblastoma cells (SH-SY5Y). 2. The Na+ conductance in differentiated SH-SY5Y cells (24.0 +/- 2.4 nS, n = 11) was half-maximally activated by 10 ms depolarizations to -37 +/- 2 mV and was half-maximally inactivated by predepolarizing pulses of 200 ms duration to -86 +/- 3 mV (n = 11). 3. At low stimulus frequencies (0.1 to 0.33 Hz) voltage-dependent sodium currents were completely blocked, in a concentration-dependent manner, by extracellular application of either tetrodotoxin (EC50 = 4 +/- 1 nM, n = 12) or by lifarizine (EC50 = 783 +/- 67 nM, n = 9). The onset of block by lifarizine (tau = 91 +/- 14 s at 10 microM) was considerably slower than that of tetrodotoxin (tau = 16 +/- 3 s at 100 nM). 4. Lifarizine (1 microM) reduced the peak sodium conductance in each cell (from 26.4 +/- 2.0 nS to 15.1 +/- 2.7 nS, n = 4) without changing the macroscopic kinetics of sodium current activation or inactivation (V1/2 = -35 1 mV and -87 +/- 4 mV respectively, n = 4). Similarly, lifarizine (1 microM) did not affect the reversal potential of the macroscopic sodium current (+14 +/- 5 mV in control and +16 +/- 2 mV in 1 microM lifarizine; n = 4) or reactivation time-constant (tau = 14.0 +/- 4.4 ms). 5. Block of the sodium channel open state by tetrodotoxin (30 nM) did not prevent the inhibition caused by a subsequent application of lifarizine (3 micro M). In contrast the depression caused by lifarizinewas readily reversible after pretreatment of cells with the local anaesthetic, lignocaine (1O mM).6. These data demonstrate that lifarizine is a use- and voltage-dependent antagonist of human voltage sensitive sodium currents. The slow kinetics and pharmacology of the block by lifarizine indicate that access of this drug to the channel is more restricted than that of tetrodotoxin and may involve an allosteric site or state of the channel that is also regulated by local anaesthetics.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834213      PMCID: PMC1510106          DOI: 10.1111/j.1476-5381.1994.tb17032.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

Review 1.  Cellular and molecular biology of voltage-gated sodium channels.

Authors:  W A Catterall
Journal:  Physiol Rev       Date:  1992-10       Impact factor: 37.312

Review 2.  Models of drug interaction with the sodium channel.

Authors:  A O Grant
Journal:  Clin Invest Med       Date:  1991-10       Impact factor: 0.825

3.  Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel.

Authors:  M E Gellens; A L George; L Q Chen; M Chahine; R Horn; R L Barchi; R G Kallen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

4.  Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo.

Authors:  A L HODGKIN; A F HUXLEY
Journal:  J Physiol       Date:  1952-04       Impact factor: 5.182

5.  Characterization of two components of the N-like, high-threshold-activated calcium channel current in differentiated SH-SY5Y cells.

Authors:  E P Seward; G Henderson
Journal:  Pflugers Arch       Date:  1990-10       Impact factor: 3.657

6.  Expression of functional sodium channels from cloned cDNA.

Authors:  M Noda; T Ikeda; H Suzuki; H Takeshima; T Takahashi; M Kuno; S Numa
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

7.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

8.  The site of action and active form of local anesthetics. II. Experiments with quaternary compounds.

Authors:  D T Frazier; T Narahashi; M Yamada
Journal:  J Pharmacol Exp Ther       Date:  1970-01       Impact factor: 4.030

9.  Batrachotoxin uncouples gating charge immobilization from fast Na inactivation in squid giant axons.

Authors:  J Tanguy; J Z Yeh
Journal:  Biophys J       Date:  1988-10       Impact factor: 4.033

Review 10.  Drugs acting on calcium channels: potential treatment for ischaemic stroke.

Authors:  B J Alps
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

View more
  6 in total

1.  Constitutive activity of the A2A adenosine receptor and compartmentalised cyclic AMP signalling fine-tune noradrenaline release.

Authors:  Edin Ibrisimovic; Helmut Drobny; Qiong Yang; Thomas Höfer; Stefan Boehm; Christian Nanoff; Klaus Schicker
Journal:  Purinergic Signal       Date:  2012-04-05       Impact factor: 3.765

2.  Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL.

Authors:  A J Carter; M Grauert; U Pschorn; W D Bechtel; C Bartmann-Lindholm; Y Qu; T Scheuer; W A Catterall; T Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Actions of the novel neuroprotective agent, lifarizine (RS-87476), on voltage-dependent sodium currents in the neuroblastoma cell line, N1E-115.

Authors:  J G McGivern; L Patmore; R D Sheridan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

4.  Neuroprotective profile of lifarizine (RS-87476) in rat cerebrocortical neurones in culture.

Authors:  G R May; W S Rowand; J G McCormack; R D Sheridan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Enhanced Hyaluronan Signaling and Autophagy Dysfunction by VPS35 D620N.

Authors:  Abir A Rahman; Alejandro Soto-Avellaneda; Hyun Yong Jin; Iva Stojkovska; Nathan K Lai; Joshua E Albright; Abby R Webb; Emily Oe; Jacob P Valarde; Alexandra E Oxford; Paige E Urquhart; Brandon Wagner; Connor Brown; Isabella Amado; Peyton Vasquez; Nicholas Lehning; Veselin Grozdanov; Xinzhu Pu; Karin M Danzer; Brad E Morrison
Journal:  Neuroscience       Date:  2020-06-13       Impact factor: 3.590

6.  N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity.

Authors:  Bryce Keenan; Rocio K Finol-Urdaneta; Ashleigh Hope; John B Bremner; Maria Kavallaris; Daniel Lucena-Agell; María Ángela Oliva; Jose Fernando Díaz; Kara L Vine
Journal:  Cancer Cell Int       Date:  2020-05-15       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.